Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
Nikunj J Shah, Urmi N Shah
Indian Journal of Ophthalmology · 2011
doi:10.4103/0301-4738.82005 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The purpose of the study was to report a case of choroidal neovascularization (CNV) secondary to ocular toxoplasmosis in an 18-year-old female patient. She was treated with a single intravitreal injection of ranibizumab. The CNV resolved as confirmed by fluorescein angiography and optical coherence tomography (OCT). The visual acuity improved to 20/30, which was maintained till the last follow-up visit at two years, without requisition of a repeat injection.
Abstract licence: CC BY-NC-SA
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.